Hyloris Pharmaceuticals
Belgium - LiègePharmaceutical
Focus: Hyloris Pharmaceuticals is a Belgium-based pharmaceutical company specializing in reformulating existing therapies, currently operating with 51-200 employees as a public-stage enterprise.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
3
Should You Work at Hyloris Pharmaceuticals?
AI assessmentHyloris is a specialized, lower-growth reformulation company suitable for candidates prioritizing stability and niche expertise over rapid career acceleration and pipeline breadth.
Why Work Here
- Focused niche strategy in therapy reformulation offers deep specialization in a specific drug development discipline
- Public company status provides structural stability and potential equity upside for employees
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
3 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Tranexamic acid
Bleeding From TeethClinical Trials (1)
NCT06143787Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction
Phase 3Help build intelligence for Hyloris Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.